TRX-221

· Therapex Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRX-221, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients [Phase 1, Phase 2]

See pricing